Aspyra, Inc. (AMEX: APY) announced today that the Company has entered into an agreement with Springfield Clinic, LLP, one of the largest multi-specialty physicians groups in Illinois, to upgrade the laboratory�s existing LIS to the most current release of Aspyra�s CyberLAB� Laboratory Information System (LIS) solution, version 7.2.

Springfield Clinic has been an Aspyra LIS customer since 1996. The clinic�s laboratory network, which is Commission of Office Laboratory Accreditation (COLA), and College of American Pathologists (CAP) accredited, is comprised of 20 locations servicing nearly 200 physicians in 40 specialties.

�Aspyra continues to enhance the CyberLAB system with features and functions we want to take full advantage of, such as the ability to generate our own user-defined reports and queries using the SQL database,� stated Lesli Wilson, Springfield Clinic�s LIS Coordinator. She continued, �Since we will be using CyberLAB 7.2 on a Windows platform, the server will integrate nicely into our existing network infrastructure, making the overall system administration simple to manage.�

With the clinic�s goal of creating a health system where medicine and patient care are enhanced by innovation and technology, and a service philosophy to enhance and extend the qualify of life for their patients, the clinic�s physicians have immediate access to clinical patient data via the connectivity and data sharing between Aspyra�s CyberLAB LIS and Allscripts TouchWorks EMR. �For almost 10 years, Aspyra has been providing Springfield Clinic with advanced features to grow their business while maintaining service excellence. The data connectivity between our CyberLAB LIS and their Allscripts EMR is a key element in providing a complete patient electronic health record with a positive patient experience,� stated Michelle Del Guercio, Aspyra�s Vice President of Marketing.

Aspyra�s CyberLAB LIS is a scalable, feature-rich, and cost-effective LIS solution for hospital, clinic, and reference laboratory settings. Springfield Clinic will be implementing CyberLAB 7.2 on a Windows platform, utilizing a MS SQL database structure. CyberLAB LIS features decision support tools with auto-verification, automated clinical reporting and multisite management.

About Aspyra

Aspyra is a global provider of Health Care Information Technology (HCIT) solutions and services to the healthcare industry. The Company specializes in Clinical Information Systems (CIS), Picture Archive Communication Systems (PACS) and Clinical Image Management Systems (CIMS) for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers and orthopedic environments. Aspyra's highly scalable systems can be installed standalone or integrated to provide a single-vendor, enterprise-wide solution. For more information on Aspyra, its products and services, visit www.aspyra.com.

Safe Harbor Statement

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management as of the date of this release, including management's own knowledge and assessment of the Company's industry, customers and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: changes in the Company�s management or other personnel, the competitive environment for Company products and services; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in the Company�s long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.

Aspyra (AMEX:APY)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Aspyra.
Aspyra (AMEX:APY)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Aspyra.